Michael K. Fenwick

1.1k total citations
43 papers, 831 citations indexed

About

Michael K. Fenwick is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael K. Fenwick has authored 43 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael K. Fenwick's work include Heart Failure Treatment and Management (7 papers), Protein Structure and Dynamics (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael K. Fenwick is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Protein Structure and Dynamics (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael K. Fenwick collaborates with scholars based in United States, United Kingdom and Sweden. Michael K. Fenwick's co-authors include Fernando A. Escobedo, S.E. Ealick, Robert E. Oswald, Tadhg P. Begley, Allan D. Struthers, Benjamin Philmus, Ahmed H. Ahmed, Yorgo Modis, Hening Lin and Peter Cresswell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Michael K. Fenwick

42 papers receiving 817 citations

Peers

Michael K. Fenwick
Sara Núñez United States
Sarah Williams United States
Yusheng Xiong United States
Bela Ruzsicska United States
Bruce D. Ray United States
Michael K. Fenwick
Citations per year, relative to Michael K. Fenwick Michael K. Fenwick (= 1×) peers Lennart Lundberg

Countries citing papers authored by Michael K. Fenwick

Since Specialization
Citations

This map shows the geographic impact of Michael K. Fenwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Fenwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Fenwick more than expected).

Fields of papers citing papers by Michael K. Fenwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Fenwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Fenwick. The network helps show where Michael K. Fenwick may publish in the future.

Co-authorship network of co-authors of Michael K. Fenwick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Fenwick. A scholar is included among the top collaborators of Michael K. Fenwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Fenwick. Michael K. Fenwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Hernández, Diego, Michael K. Fenwick, Banumathi Sankaran, et al.. (2024). Exploring Subsite Selectivity withinPlasmodium vivaxN-Myristoyltransferase Using Pyrazole-Derived Inhibitors. Journal of Medicinal Chemistry. 67(9). 7312–7329.
2.
Jana, Sadhan, Jialin Shang, Jun Young Hong, et al.. (2024). A Mitochondria-Targeting SIRT3 Inhibitor with Activity against Diffuse Large B Cell Lymphoma. Journal of Medicinal Chemistry. 67(17). 15428–15437. 5 indexed citations
3.
Rodríguez‐Hernández, Diego, Kamalakannan Vijayan, Michael K. Fenwick, et al.. (2023). Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts. Nature Communications. 14(1). 5408–5408. 19 indexed citations
4.
Fenwick, Michael K., Yi Liu, Banumathi Sankaran, et al.. (2023). Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development. ACS Infectious Diseases. 9(10). 1821–1833. 2 indexed citations
5.
Zhang, Yugang, Dan Su, Boris Dzikovski, et al.. (2021). Dph3 Enables Aerobic Diphthamide Biosynthesis by Donating One Iron Atom to Transform a [3Fe–4S] to a [4Fe–4S] Cluster in Dph1–Dph2. Journal of the American Chemical Society. 143(25). 9314–9319. 9 indexed citations
6.
Fenwick, Michael K. & S.E. Ealick. (2020). Structural basis of elongation factor 2 switching. SHILAP Revista de lepidopterología. 2. 25–34. 2 indexed citations
7.
Fenwick, Michael K., Dan Su, Min Dong, Hening Lin, & S.E. Ealick. (2020). Structural Basis of the Substrate Selectivity of Viperin. Biochemistry. 59(5). 652–662. 23 indexed citations
8.
Fenwick, Michael K., Min Dong, Hening Lin, & S.E. Ealick. (2019). The Crystal Structure of Dph2 in Complex with Elongation Factor 2 Reveals the Structural Basis for the First Step of Diphthamide Biosynthesis. Biochemistry. 58(43). 4343–4351. 12 indexed citations
9.
Dong, Min, Michael K. Fenwick, Andrew T. Torelli, et al.. (2018). Organometallic and radical intermediates reveal mechanism of diphthamide biosynthesis. Science. 359(6381). 1247–1250. 53 indexed citations
10.
Fenwick, Michael K. & S.E. Ealick. (2018). Towards the structural characterization of the human methyltransferome. Current Opinion in Structural Biology. 53. 12–21. 8 indexed citations
11.
Fenwick, Michael K., Yue Li, Peter Cresswell, Yorgo Modis, & S.E. Ealick. (2017). Structural studies of viperin, an antiviral radical SAM enzyme. Proceedings of the National Academy of Sciences. 114(26). 6806–6811. 64 indexed citations
12.
Fenwick, Michael K., Angad P. Mehta, Yang Zhang, et al.. (2015). Non-canonical active site architecture of the radical SAM thiamin pyrimidine synthase. Nature Communications. 6(1). 6480–6480. 29 indexed citations
13.
Fenwick, Michael K. & Robert E. Oswald. (2010). On the Mechanisms of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptor Binding to Glutamate and Kainate. Journal of Biological Chemistry. 285(16). 12334–12343. 24 indexed citations
14.
Fenwick, Michael K. & Fernando A. Escobedo. (2009). Exploration of Factors Affecting the Onset and Maturation Course of Follicular Lymphoma through Simulations of the Germinal Center. Bulletin of Mathematical Biology. 71(6). 1432–1462. 6 indexed citations
15.
Fenwick, Michael K. & Robert E. Oswald. (2008). NMR Spectroscopy of the Ligand-Binding Core of Ionotropic Glutamate Receptor 2 Bound to 5-Substituted Willardiine Partial Agonists. Journal of Molecular Biology. 378(3). 673–685. 27 indexed citations
16.
Oswald, Robert E., et al.. (2007). Structure of Glutamate Receptors. Current Drug Targets. 8(5). 573–582. 29 indexed citations
17.
Fenwick, Michael K. & Robert E. Oswald. (2007). Backbone chemical shift assignment of a glutamate receptor ligand binding domain in complexes with five partial agonists. Biomolecular NMR Assignments. 1(2). 241–243. 5 indexed citations
18.
Fenwick, Michael K. & Fernando A. Escobedo. (2002). Hybrid Monte Carlo with multidimensional replica exchanges: Conformational equilibria of the hypervariable regions of a llama VHH antibody domain. Biopolymers. 68(2). 160–177. 20 indexed citations
19.
Motwani, Joseph G., Michael K. Fenwick, John J. Morton, & Allan D. Struthers. (1994). Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease. The American Journal of Cardiology. 73(16). 1191–1196. 6 indexed citations
20.
Motwani, Joseph G., et al.. (1993). Effectiveness of captopril in reversing renal vasoconstriction after Q-wave acute myocardial infarction. The American Journal of Cardiology. 71(4). 281–286. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026